Global Cryosurgery Systems Market Research Report 2022

Cryosurgery Systems provide an accepted treatment modality within the fields of dermatology, oral surgery, gynecology, urology, otolaryngology, proctology, and ophthalmology. They can be used to treat malignant and benign tumors, acne, warts, and hemorrhoids. Cryosurgery Systems (CSUs) apply a refrigerant (cryogen) to withdraw heat from target tissue either through direct application or indirectly through contact with a cryogen-cooled probe.
Due to the COVID-19 pandemic, the global Cryosurgery Systems market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, the Europe Cryosurgery Systems market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Cryosurgery Systems landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Tissue Contact Probes accounting for % of the Cryosurgery Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Surgeries segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Cryosurgery Systems include CryoConcepts, Erbe, CooperSurgical, Brymill, Medtronic, Varian, CSA Medical, Cortex Technology and AtriCure, etc. In terms of revenue, the global 3 largest players have a % market share of Cryosurgery Systems in 2021.
This report focuses on Cryosurgery Systems volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cryosurgery Systems market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Cryosurgery Systems Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Tissue Contact Probes
Tissue Spray Probes
Epidermal and Subcutaneous Cryoablation Devices
Cryoablation Devices
Segment by Application
Surgeries
Pain Management
Recovery, Health, and Beauty
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
CryoConcepts
Erbe
CooperSurgical
Brymill
Medtronic
Varian
CSA Medical
Cortex Technology
AtriCure
METRUM CRYOFLEX
Keeler Instruments
Epimed
OPTIKON
inomed
EROND
Toitu
MedGyn
H&O Equipments
Clinic6
Cryoswiss

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-19998614

14-Jan-2022

117
License